TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 3,178,322 | 2,404,254 | 2,887,015 |
Earnings before taxes | -360,400 | -590,111 | -193,015 |
Total assets | 4,898,127 | 5,007,604 | 5,782,387 |
Current assets | 1,515,900 | 1,756,724 | 2,412,557 |
Current liabilities | 1,550,626 | 1,218,533 | 977,137 |
Equity capital | 2,478,155 | 2,793,346 | 3,704,723 |
- share capital | 284,524 | 269,579 | 284,106 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 50.6% | 55.8% | 64.1% |
Turnover per employee | 9,081 | 6,869 | 8,249 |
Profit as a percentage of turnover | -11.3% | -24.5% | -6.7% |
Return on assets (ROA) | |||
Current ratio | 97.8% | 144.2% | 246.9% |
Return on equity (ROE) | -14.5% | -21.1% | -5.2% |
Change turnover | 640,784 | -335,149 | -429,383 |
Change turnover % | 25% | -12% | -13% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.